SCHEMBL533752

SCHEMBL533752

CC(C)(C)OC(=O)N(c1ccc(Br)c(C(N)(Cc2ccc(-c3ccccc3)nn2)S(=O)(=O)c2cccnc2)n1)C(C(=O)O)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL533426 0.90 PTGER2 (0.32) —
SCHEMBL533751 0.88 — —
SCHEMBL3458643 0.87 PTGER2 (0.32) —
SCHEMBL3458639 0.82 — —
SCHEMBL533749 0.82 PTGER2 (0.39) —
SCHEMBL533748 0.81 SLC1A3 (0.32) —
SCHEMBL533750 0.79 USP2 (0.31) —
SCHEMBL533427 0.78 PTGER2 (0.47) —
SCHEMBL534324 0.77 PTGER2 (0.38) —
SCHEMBL3458635 0.77 PTGER2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8648097-B2 Pyridylaminoacetic acid compound UBE INDUSTRIES, LTD. (JP) 2014-02-11 — — US disclosed
EP-2415763-A1 PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING GLAUCOMA Ube Industries, Ltd. (JP) 2012-02-08 — — EP disclosed
Send feedback